Large-scale testing (Phase 3)Study completedNCT00150618
What this trial is testing
Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17
Who this might be right for
Attention Deficit Disorder With Hyperactivity
Shire 324